Prognostic role of long noncoding RNA CASC11 in cancer patients: A meta-analysis

Song Zhang, Bo Xu, Ji-Ling Zhang, Shun-Hai Liu, Xin Xiang, Pan Liu · 2024

Read Prognostic role of long noncoding RNA CASC11 in cancer patients: A meta-analysis by Song Zhang, Bo Xu, Ji-Ling Zhang, Shun-Hai Liu, Xin Xiang, Pan Liu (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11651512.txt.

Description

A long stretch of RNA that codes for no protein can still shadow the future of a cancer patient. Song Zhang and co-authors pool the evidence on one such molecule, CASC11, in a 2024 meta-analysis. Individual studies had linked its expression level to tumor growth and patient survival.

Searching four databases through September 2023, the team found eleven studies covering 660 patients. They combined hazard ratios for overall survival and odds ratios for clinical features. The pooled picture tests whether high CASC11 marks more aggressive disease and shorter lives. A firm answer would support the molecule as both a prognostic biomarker and a possible drug target. The paper weighs the consistency of the small-study record.

Catalog record

CREATORSong Zhang, Bo Xu, Ji-Ling Zhang, Shun-Hai Liu, Xin Xiang, Pan Liu
YEAR2024
COLLECTIONPAPERS
FORMATTXT
FILE SIZE22 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC11651512

Browse the full library · About the Tower of Babel